Chemotherapy for Chronic Lymphocytic Leukemia

The chronic lymphocytic leukemias (CLL) are a diverse group of white blood cell cancers.

CLL is the most prevalent leukemia in the United States and Europe; an estimated 85,000 Americans are living with CLL in 2008. The complexity and variability of this group of hematologic malignancies results in numerous diagnostic and treatment challenges. A myriad of therapeutic options is available and more are on the horizon. Recent research has yielded increased understanding and insight into the pathophysiology and molecular biology of CLL and related cancers.

Part of the Oxford American Pocket Cards series, this concise, ultra-portable, up-to-date and attractively designed medical reference card provides essential clinical tools to aid the busy clinician in the diagnosis and treatment of CLL at the point of care.

To purchase this product, please contact U.S. Medical Sales at MedSales@oup.com List price- $7.95